These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11324691)

  • 21. Role of costimulatory molecules in autoimmunity.
    Kobata T; Azuma M; Yagita H; Okumura K
    Rev Immunogenet; 2000; 2(1):74-80. PubMed ID: 11324695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic science for the clinician 36: protecting against autoimmunity: tolerance and aire, the immunologic shadow, and other mechanisms of negative selection in the thymus.
    Sigal LH
    J Clin Rheumatol; 2006 Feb; 12(1):44-6. PubMed ID: 16484883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymic microenvironments for T-cell repertoire formation.
    Nitta T; Murata S; Ueno T; Tanaka K; Takahama Y
    Adv Immunol; 2008; 99():59-94. PubMed ID: 19117532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad.
    Wagner DH
    Clin Immunol; 2007 Apr; 123(1):1-6. PubMed ID: 16990051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmunity and B-cell malignancies.
    Dighiero G
    Hematol Cell Ther; 1998 Feb; 40(1):1-9. PubMed ID: 9556183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinant spreading and the dynamics of the autoimmune T-cell repertoire.
    Lehmann PV; Sercarz EE; Forsthuber T; Dayan CM; Gammon G
    Immunol Today; 1993 May; 14(5):203-8. PubMed ID: 7686009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Learning to be tolerant: how T cells keep out of trouble.
    Holländer GA; Peterson P
    J Intern Med; 2009 May; 265(5):541-61. PubMed ID: 19382993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes.
    Sacher T; Knolle P; Nichterlein T; Arnold B; Hämmerling GJ; Limmer A
    Eur J Immunol; 2002 Dec; 32(12):3628-37. PubMed ID: 12516551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology of autoimmune disease: how T cells escape self-tolerance.
    Sercarz E; Raja-Gabaglia C
    Methods Mol Biol; 2007; 380():271-83. PubMed ID: 17876099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymus-dependent T cell tolerance of neuroendocrine functions: principles, reflections, and implications for tolerogenic/negative self-vaccination.
    Geenen V
    Ann N Y Acad Sci; 2006 Nov; 1088():284-96. PubMed ID: 17192574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoires.
    Sarma S; Bai XF; Liu JQ; May KF; Zheng P; Liu Y
    Cancer Res; 2003 Sep; 63(18):6051-5. PubMed ID: 14522934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Set a thief to catch a thief: self-reactive innate lymphocytes and self tolerance.
    Kristóf K; Erdei A; Bajtay Z
    Autoimmun Rev; 2008 Feb; 7(4):278-83. PubMed ID: 18295730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mimicry between non-self, modified self and self in autoimmunity.
    Karlsen AE; Dyrberg T
    Semin Immunol; 1998 Feb; 10(1):25-34. PubMed ID: 9529653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of immunity by self-reactive T cells.
    Kronenberg M; Rudensky A
    Nature; 2005 Jun; 435(7042):598-604. PubMed ID: 15931212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The unveiling of hidden T-cell determinants of a native antigen by defined mediators of inflammation: implications for the pathogenesis of autoimmunity.
    Jiang X; Moudgil KD
    Scand J Immunol; 2006 May; 63(5):338-46. PubMed ID: 16640657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing self-reactivity in cancer immunotherapy.
    Schoenberger SP; Sercarz EE
    Semin Immunol; 1996 Oct; 8(5):303-9. PubMed ID: 8956459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selecting and maintaining a diverse T-cell repertoire.
    Goldrath AW; Bevan MJ
    Nature; 1999 Nov; 402(6759):255-62. PubMed ID: 10580495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymic regulatory T cells.
    Maggi E; Cosmi L; Liotta F; Romagnani P; Romagnani S; Annunziato F
    Autoimmun Rev; 2005 Nov; 4(8):579-86. PubMed ID: 16214099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.